0001209191-20-033291.txt : 20200601 0001209191-20-033291.hdr.sgml : 20200601 20200601180519 ACCESSION NUMBER: 0001209191-20-033291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200601 FILED AS OF DATE: 20200601 DATE AS OF CHANGE: 20200601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hindman James M. CENTRAL INDEX KEY: 0001617615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 20935040 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Urovant Sciences Ltd. CENTRAL INDEX KEY: 0001740547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 BUSINESS PHONE: 949-226-6029 MAIL ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-01 0 0001740547 Urovant Sciences Ltd. UROV 0001617615 Hindman James M. C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVE, SUITE 100 IRVINE CA 92617 1 0 0 0 Stock Option (Right to Buy) 10.53 2020-06-01 4 A 0 61000 0.00 A 2030-06-01 Common Shares 61000 61000 D The shares underlying the option shall vest and become exercisable in three equal annual installments beginning on June 1, 2021, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date. /s/ Bryan Smith, Attorney-in-Fact 2020-06-01